Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
The story of Amgen began more than three decades ago with a simple idea - that emerging research in genetics could lead to very exciting opportunities if the right scientists could be assembled and given the appropriate resources.
Amgen has since grown to be the world’s largest independent biotechnology company, launching some of the biotechnology industry’s first blockbuster therapies, and subsequently changing the course of medicine. Focusing on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience, our medicines address diseases for which the number of effective treatment options is limited, or they are medicines that provide a viable option to what is otherwise available.
With a presence in approximately 100 countries worldwide, Amgen continues to develop a pipeline of medicines with breakaway potential, reaching millions of patients around the world in the fight against serious illnesses. We could not have accomplished what we did were it not for our mission to serve patients and a commitment to build a culture that embraces science and innovation - drivers that continue to shape who we are today.
Our revolutionary Next Generation Biomanufacturing facility - built with state-of-the-art modular, reconfigurable design that can be replicated in future facilities and our second facility for large molecule chemical synthesis manufacturing located at Tuas Biomedical Park in Singapore offers immense opportunities for professionals and graduates to achieve their fullest potential and to make a positive difference in people’s lives. With a vibrant culture where staff are empowered and united by our values, Amgen supports a variety of growth opportunities to foster an environment in which all staff may excel.
Come discover how you can join Amgen Singapore and work in an innovative and exciting place to make a difference for millions of people around the world.